top of page
Search


Cyclone Metals Limited (ASX: CLE) – Iron Bear Project Scoping Study Positions Company for Large-Scale, Low-Carbon Magnetite Production - A Green Iron Ore and Green Steel Story Unfolding.
Cyclone Metals Limited (ASX: CLE) has released the results of its Scoping Study for the flagship Iron Bear Project, located in the Labrador Trough, Canada — a region that has been a cornerstone of North America’s iron ore industry for over 70 years. The study outlines the potential for a world-class, long-life magnetite operation, producing premium iron ore products that are aligned with the growing demand for low-carbon “green steel”.

Noel Ong
Aug 139 min read


Ion Exchange and Nanofiltration Redefine Rare Earth Processing Flowsheet - First Mover Advantage for OD6 Limited? Is It Time for Investors?
OD6 Metals Limited (ASX: OD6) has announced a significant step forward in rare earth processing at its flagship Splinter Rock Rare Earth Element (REE) Project in Western Australia (Figure 1). The integration of Ion Exchange (IX) and Nanofiltration (NF) technologies into the heap leach flowsheet is yielding transformational results—enhancing impurity removal, reducing acid consumption, and increasing recovery efficiency.

Noel Ong
Aug 138 min read


High-Grade Discovery of Gallium - Ida Holmes Junction Project.
Western Yilgarn Limited (ASX: WYX) has confirmed a significant surface discovery of high-grade gallium mineralisation at its Ida Holmes Junction Project in the Yilgarn Craton, Western Australia (Figure 1). With gallium identified by global authorities as a technology-critical element essential for semiconductors, LEDs, and solar panels, this development could place Western Yilgarn on the radar of strategic investors and downstream supply chain partners.

Noel Ong
Aug 136 min read


AML3D (ASX: AL3) Expands into Europe with UK Distribution Partnership - Defence Manufacturing Business.
AML3D Limited (ASX: AL3), a pioneer in industrial-scale metal 3D printing, continues its global expansion with the announcement of a strategic UK distribution agreement. The company has appointed Arc Additive Limited, a Scotland-based specialist in wire arc additive manufacturing (WAAM), as its non-exclusive distribution partner across the UK and Europe.

Noel Ong
Aug 134 min read


Lion Rock Minerals Limited (ASX: LRM) - A Critical Mineral Breakthrough in Cameroon: Rutile, Monazite, Zircon and Rare Earths Take Centre Stage.
Peak Minerals Limited (ASX: PUA) has confirmed a major expansion of heavy mineral (HM) mineralisation at its flagship Minta Rutile Project in Cameroon, with a 100% success rate from all 452 holes drilled (Figure 1). The program identified mineralisation across a vast 1,500km² zone—demonstrating scale and consistency in both residual and alluvial targets.

Noel Ong
Aug 125 min read


A Global Cybersecurity Narrative in Motion: Defence-Grade Trust Fuels archTIS Momentum.
In the data security arena, momentum is everything, and archTIS Limited (ASX: AR9) is building a convincing narrative across multiple strategic fronts. From headline contract wins with the U.S. Department of Defense to entering the UK defence sector and securing fresh funding to fuel expansion, the Company has demonstrated alignment between strategic intent and market execution.

Noel Ong
Aug 116 min read


AuMEGA Metals Ltd (ASX: AAM) Mineral Exploration Update – July 2025 Unlocking Discovery Potential Across Cape Ray, Bunker Hill and Hermitage.
In its 29 July 2025 announcement, AuMEGA Metals Ltd (ASX: AAM | TSXV: AUM | OTCQB: AUMMF) delivered a substantial exploration update covering three major Canadian projects—Cape Ray, Bunker Hill, and Hermitage. With a fully funded program and a strong C$9.2 million treasury, AuMEGA is aggressively expanding its data-driven strategy across Newfoundland’s Cape Ray Shear Zone, Canada’s largest known gold-bearing structure.

Noel Ong
Aug 106 min read


Alterity Therapeutics (ASX: ATH) Advances Neurodegenerative Drug Development - Multiple system Atrophy.
Alterity Therapeutics Limited (ASX: ATH; NASDAQ: ATHE) has announced highly promising topline results from its open-label Phase 2 clinical trial (ATH434-202) evaluating ATH434 in patients with advanced Multiple System Atrophy (MSA). The findings reinforce the company’s position as a front-runner in developing disease-modifying therapies for neurodegenerative diseases.

Noel Ong
Aug 87 min read


Actinogen Medical Limited (ASX:ACW) Reaches Critical Milestone with 100th Patient in XanaMIA Alzheimer’s Trial.
Actinogen Medical Ltd (ASX: ACW) has announced a significant milestone in the development of its lead candidate, Xanamem®(emestedastat), with the 100th participant now enrolled in its pivotal XanaMIA Phase 2b/3 Alzheimer’s disease trial. This event formally triggers the timeline for an independent interim analysis of safety and efficacy, bringing the company one step closer to potentially introducing a novel oral therapy for Alzheimer’s disease (AD).

Noel Ong
Aug 77 min read


Exploring Emerging Investment Markets Across the Globe
Investing in emerging markets offers exciting opportunities for growth and diversification. These markets, often characterized by rapid economic development and increasing integration into the global economy, can provide higher returns compared to developed markets. However, they also come with unique risks and challenges. This article explores some of the most promising emerging investment markets worldwide, highlighting key sectors, trends, and practical tips for investors.

Noel Ong
Aug 65 min read
bottom of page
